Neuronetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuronetics and other ETFs, options, and stocks.About STIM
Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments.
CEOKeith J. Sullivan
CEOKeith J. Sullivan
Employees716
Employees716
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded1998
Founded1998
Employees716
Employees716
STIM Key Statistics
Market cap106.50M
Market cap106.50M
Price-Earnings ratio-1.87
Price-Earnings ratio-1.87
Dividend yield—
Dividend yield—
Average volume1.33M
Average volume1.33M
High today$1.53
High today$1.53
Low today$1.53
Low today$1.53
Open price$1.64
Open price$1.64
Volume1.06K
Volume1.06K
52 Week high$5.92
52 Week high$5.92
52 Week low$1.23
52 Week low$1.23
Stock Snapshot
As of today, Neuronetics(STIM) shares are valued at $1.53. The company's market cap stands at 106.5M, with a P/E ratio of -1.87.
On 2025-12-18, Neuronetics(STIM) stock moved within a range of $1.53 to $1.53. With shares now at $1.53, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 1.06K, compared to an average daily volume of 1.33M.
The stock's 52-week range extends from a low of $1.23 to a high of $5.92.
The stock's 52-week range extends from a low of $1.23 to a high of $5.92.
STIM News
Simply Wall St 5d
Would Neuronetics Be Better Off With Less Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural t...
People also own
Based on the portfolios of people who own STIM. This list is generated using Robinhood data, and it’s not a recommendation.